Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | AMGN | REGN | VRTX | GILD |
| Company | Dicerna Pharmaceutic | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 38.21 | 317.63 | 1,040.49 | 462.60 | 83.33 |
| High | 38.24 | 320.67 | 1,045.95 | 468.07 | 85.43 |
| Low | 38.21 | 316.18 | 1,025.97 | 460.55 | 83.10 |
| Last | 38.22 | 319.73 | 1,040.27 | 462.14 | 84.74 |
| Change | +0.22 | -0.59 | -6.64 | -7.62 | +0.80 |
| % Change | +0.58% | -0.18% | -0.63% | -1.62% | +0.95% |
| Volume | 5,568,900 | 2,614,400 | 687,000 | 897,200 | 6,042,300 |
| 20-Day Average Volume | 3,647,665 | 2,158,280 | 653,145 | 973,815 | 7,983,175 |
| Previous Close | 38.00 | 320.32 | 1,046.91 | 469.76 | 83.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 327.50 | 1,107.32 | 470.63 | 82.61 |
| 20-Day Raw Stochastic | 90.72% | 28.03% | 19.11% | 17.81% | 91.09% |
| 20-Day Relative Strength | 80.40% | 44.80% | 35.67% | 43.52% | 69.29% |
| Weighted Alpha | +35.17 | +18.10 | +20.50 | +23.98 | +19.73 |
| Today's Opinion | 88% Buy | 24% Buy | 24% Buy | 8% Buy | 88% Buy |
| Previous Opinion | 72% Buy | 24% Buy | 24% Buy | 8% Buy | 88% Buy |
| Last Month's Opinion | 24% Buy | 96% Buy | 100% Buy | 48% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | +2.20% since 09/25/24 | +0.88% since 09/25/24 | +0.08% since 09/25/24 | +3.08% since 09/25/24 |
| Low | 37.81 on 12/21/21 | 313.37 on 09/26/24 | 1,025.97 on 10/02/24 | 458.10 on 09/26/24 | 81.83 on 09/26/24 |
| High | 38.24 on 12/27/21 | 327.98 on 09/27/24 | 1,070.00 on 09/27/24 | 472.31 on 10/01/24 | 85.43 on 10/02/24 |
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | -4.22% since 08/30/24 | -12.19% since 08/30/24 | -6.81% since 08/30/24 | +7.27% since 08/30/24 |
| Low | 37.78 on 12/10/21 | 312.16 on 09/25/24 | 1,008.41 on 09/25/24 | 456.07 on 09/24/24 | 77.74 on 09/05/24 |
| High | 38.26 on 12/03/21 | 339.17 on 09/23/24 | 1,192.54 on 09/03/24 | 493.00 on 09/03/24 | 85.43 on 10/02/24 |
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | +2.88% since 07/02/24 | -0.42% since 07/02/24 | -2.46% since 07/02/24 | +23.89% since 07/02/24 |
| Low | 19.06 on 10/06/21 | 306.11 on 07/03/24 | 1,008.41 on 09/25/24 | 456.07 on 09/24/24 | 66.01 on 07/05/24 |
| High | 38.26 on 12/03/21 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 85.43 on 10/02/24 |
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | +15.76% since 04/02/24 | +8.97% since 04/02/24 | +12.88% since 04/02/24 | +17.55% since 04/02/24 |
| Low | 19.06 on 10/06/21 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 62.07 on 05/31/24 |
| High | 40.14 on 07/20/21 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 85.43 on 10/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 171,830,864 | 115,354,816 | 121,222,976 | 104,576,912 |
| Shares Outstanding, K | 78,129 | 536,435 | 110,186 | 258,053 | 1,245,853 |
| Annual Sales | 164,310,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -112,750,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 62,950,000 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 6,954,000,000 |
| Last Quarter Net Income | -17,070,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,614,000,000 |
| 60-Month Beta | 0.80 | 0.61 | 0.12 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/09/21 | 10/30/24 | 10/31/24 | 11/04/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.32 | 27.36 | 0.00 | 17.84 |